VitaLonga

Human study · Aging · 19 Nov 2026

In 436,469 participants, clonal hematopoiesis lined up with a small rise in cataract, macular degeneration, and diabetic eye disease

Source: GeroScience

What the research found

An original article in GeroScience was published on 19 November 2026. UK Biobank enrolled people from 2006 to 2010 and followed records through March 2022. Clonal hematopoiesis of indeterminate potential meant a somatic driver mutation at a variant allele fraction of at least 2 percent. The models were Cox models. Diabetic retinopathy was limited to people who had diabetes. Of 436,469 participants, mean age was 56.4 years, and 54.5 percent were women. 14,110 (3.2 percent) had clonal hematopoiesis. Over a median of 14.4 years the counts were 31,165 with cataract, 12,393 with glaucoma, 13,644 with age-related macular degeneration, and 2,692 with diabetic retinopathy. Hazard ratios were 1.08 (95 percent CI 1.03 to 1.14) for cataract, 1.12 (1.04 to 1.21) for age-related macular degeneration, and 1.48 (1.25 to 1.74) for diabetic retinopathy. Glaucoma overall was 1.08 (0.99 to 1.17) and was not significant. Glaucoma in people without hypertension was 1.22 (1.06 to 1.40), with an interaction p of 0.012. The associations varied by clone size and by driver gene. Hematologic and inflammatory biomarkers accounted for less than 5 percent of the association. Except for diabetic retinopathy, the effect sizes were small. This is not a screening test. DOI 10.1007/s11357-026-02679-w. Not medical advice.

Evidence level: Human study. A study in people, but an association isn't proof of cause.

Read the original at GeroScience

More aging news